TNFRSF1A and autoimmune hepatitis: Taken together, the disparate function of TNFR1 and TNFR2 in T cell immunity underscores the necessity to selectively analyse their cell-specific role in preclinical mouse models of immune-mediated liver injury and to develop novel therapeutic agents that selectively block TNFR1 and, on the contrary, selectively activate TNFR2 for treatment of autoimmune liver disease.